When and how to use carboplatin in metastatic castration-resistant prostate cancer?

A Omlin; S Gillessen

doi:10.1016/j.ejca.2018.01.001

When and how to use carboplatin in metastatic castration-resistant prostate cancer?

A Omlin
, S Gillessen

Division of Cancer Sciences (L5)

Kantonsspital St Gallen
University of Bern

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	96-99
Number of pages	4
Journal	European journal of cancer (Oxford, England : 1990)
Volume	92
DOIs	https://doi.org/10.1016/j.ejca.2018.01.001
Publication status	Published - Mar 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Carboplatin
Humans
Male
Prostatic Neoplasms, Castration-Resistant
Taxoids

Research Beacons, Institutes and Platforms

Manchester Cancer Research Centre

Access to Document

10.1016/j.ejca.2018.01.001

Cite this

@article{df4e310107784831942d7e3b38233966,

title = "When and how to use carboplatin in metastatic castration-resistant prostate cancer?",

keywords = "Carboplatin, Humans, Male, Prostatic Neoplasms, Castration-Resistant, Taxoids",

author = "A Omlin and S Gillessen",

year = "2018",

month = mar,

doi = "10.1016/j.ejca.2018.01.001",

language = "English",

volume = "92",

pages = "96--99",

journal = "European journal of cancer (Oxford, England : 1990)",